12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Deals

FDS Pharma, Opko deal

Opko will acquire a 45% stake in an undisclosed private Israeli company from FDS Pharma, which manufactures active pharmaceutical ingredients (APIs) for Russia and other markets. The Israeli company produces a third-generation HBV vaccine called...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >